[Evaluation of the effect of prodigiozan on the course of acute respiratory viral infections].
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007372:Interferons / Q000096:biosynthesis; D008297:Male; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D011354:Prodigiozan / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000517:prevention & control; D014777:Virus Diseases / Q000517:prevention & control*
D011135:Polysaccharides, Bacterial; D007372:Interferons; D011354:Prodigiozan
Otsenka deistviia prodigiozana na techenie ostrykh respiratornykh virusnykh infektsii.